FI803589L - Nya 5,10-dihydroimidazo/2,1-b/kinazoliner deras framstaellning och dessa innehaollande farmaceutiska foereningar - Google Patents

Nya 5,10-dihydroimidazo/2,1-b/kinazoliner deras framstaellning och dessa innehaollande farmaceutiska foereningar

Info

Publication number
FI803589L
FI803589L FI803589A FI803589A FI803589L FI 803589 L FI803589 L FI 803589L FI 803589 A FI803589 A FI 803589A FI 803589 A FI803589 A FI 803589A FI 803589 L FI803589 L FI 803589L
Authority
FI
Finland
Prior art keywords
quinazoliner
nya
dihydroimidazo
pharmaceutical form
deras framstaellning
Prior art date
Application number
FI803589A
Other languages
English (en)
Finnish (fi)
Inventor
Hans Ott
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI803589L publication Critical patent/FI803589L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI803589A 1979-11-24 1980-11-17 Nya 5,10-dihydroimidazo/2,1-b/kinazoliner deras framstaellning och dessa innehaollande farmaceutiska foereningar FI803589L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1045379 1979-11-24

Publications (1)

Publication Number Publication Date
FI803589L true FI803589L (fi) 1981-05-25

Family

ID=4363385

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803589A FI803589L (fi) 1979-11-24 1980-11-17 Nya 5,10-dihydroimidazo/2,1-b/kinazoliner deras framstaellning och dessa innehaollande farmaceutiska foereningar

Country Status (12)

Country Link
US (1) US4372956A (fr)
EP (1) EP0029559A3 (fr)
JP (1) JPS5699486A (fr)
AU (1) AU6460480A (fr)
DK (1) DK499180A (fr)
ES (1) ES497048A0 (fr)
FI (1) FI803589L (fr)
IL (1) IL61536A0 (fr)
PT (1) PT72086B (fr)
SU (1) SU980624A3 (fr)
YU (1) YU298180A (fr)
ZA (1) ZA807327B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5117061A (en) * 1985-04-03 1992-05-26 Ethyl Corporation Process of preparing substituted anilines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
USD1041943S1 (en) * 2022-05-12 2024-09-17 HC Systems, Inc. Toilet paper housing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745216A (en) * 1969-12-18 1973-07-10 Smith Kline French Lab Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant
SU445665A1 (ru) 1972-06-30 1974-10-05 Всесоюзный научно-исследовательский химико-фармацевтический институт им. С.Орджоникидзе Способ получени производных имидазо=/1,2=в/=хиназолона-5
US3974165A (en) * 1974-02-21 1976-08-10 Bristol-Myers Company Hypotensive agents
JPS5752352B2 (fr) * 1974-02-28 1982-11-06
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
JPS5448797A (en) * 1977-09-06 1979-04-17 Sumitomo Chem Co Ltd Tricyclic condensed pyrimidine derivative and its preparation
JPS5576878A (en) * 1978-11-14 1980-06-10 Sumitomo Chem Co Ltd Tricyclic condensed pyrimidine derivative and its acid addition salt

Also Published As

Publication number Publication date
AU6460480A (en) 1981-05-28
EP0029559A2 (fr) 1981-06-03
EP0029559A3 (fr) 1981-09-30
YU298180A (en) 1983-02-28
PT72086B (en) 1982-01-28
ES8202826A1 (es) 1982-02-16
ZA807327B (en) 1982-07-28
JPS5699486A (en) 1981-08-10
ES497048A0 (es) 1982-02-16
SU980624A3 (ru) 1982-12-07
PT72086A (en) 1980-12-01
US4372956A (en) 1983-02-08
IL61536A0 (en) 1980-12-31
DK499180A (da) 1981-05-25

Similar Documents

Publication Publication Date Title
FI803042A (fi) Nya naftyridinderivat och foerfarande foer deras framstaellning
FI802876A (fi) Nya biologiskt aktiva peptider och foerfarande foer framstaellning daerav
FI800910A (fi) Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar
FI782607A (fi) Nya 3,4,5-trihydroxipiperidinderivat foerfarande foer deras framstaellning och deras anvaendning
FI810669L (fi) Nya karbostyrilderivat foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI792009A (fi) 3-aminopropoxiarylderivat deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar
FI801640A (fi) Nya tiovinyl-3 kefalosporiner deras framstaellning och dessa innehaollande kompositioner
FI800024A (fi) Nya pleuromutilinderivat deras framstaellning och anvaendning
FI73527B (fi) Foerfarande och anordning foer samtidig maetning av de kemiska koncentrationerna av kisel- och aluminiumkomponenterna i material.
FI802165A (fi) Nya indolizinderivater och foerfarande foer framstaellning av dessa
FI802228A (fi) Nya karboxylsyraderivater deras framstaellning och deras anvaendning
FI803579L (fi) Nya 6alfa 9alfa-difluor-16-metyl-prednisolon 17,21-diestrar
FI831475L (fi) Nya azepinindoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI800381A (fi) Nya kefalosporinderivat deras framstaellning och anvaendning som antimikrobiella aemnen
FI803355L (fi) 3,6,7,8-substituerade-s-triazolo/4,3-b/pyridaziner och dessa innehaollande foereningar
FI783340A (fi) Nya 6-oxiderade 3,20-dioxo-pregnanderivat, foerfarande foer framstaellning daerav och farmaceutiska kompositioner innehaollande saodana foereningar
FI801757A (fi) Nya hydroxiamino-eburnanderivat och foerfarande foer deras framstaellning
FI803239L (fi) Nya antiinflammatoriska och immunoregulativt aktiva pyridiner och pyrimidiner
FI812190L (fi) Nya pentapeptider foerfaranden foer deras framstaellning farmaceutiska kompositioner innehaollande naemnda pentapeptider och deras anvaendning
FI802584A (fi) Nya 1,1,2-trifenylpropan- och propenderivat foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande de nya foereningarna
FI803908L (fi) Nya pyrrolobenszotriazepiner deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI77029B (fi) Foerfarande foer framstaellning av nya 3-amino-1-benzoxepinderivat och deras salter.
FI821164L (fi) Nya 2,3,4-trinor-m-inter-fenylen-prostaglandinderivat och foerfarande foer deras framstaellning
FI803589L (fi) Nya 5,10-dihydroimidazo/2,1-b/kinazoliner deras framstaellning och dessa innehaollande farmaceutiska foereningar
FI803483L (fi) Makrolidantibiotika foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SANDOZ AG